Dr. Nicholas Graham Wysham, MD

Dr. Wysham practices at Salmon Creek 1 Clinic in Vancouver, Washington.

Dr. Wysham's NPI, 1144464496, was assigned on April 29, 2009. Dr. Wysham graduated from University of Washington School of Medicine in 2009. Dr. Wysham holds Washington license MD60629767.

Dr. Wysham's primary practice is Salmon Creek 1 Clinic, at 2525 Ne 139th Street, Vancouver, WA 98686. The practice phone is (360) 882-2778.

Dr. Wysham's primary practice is Salmon Creek 1 Clinic in Vancouver, Washington. Dr. Wysham is also affiliated with PeaceHealth Southwest Medical Center. The medical group on file is Legacy Salmon Creek Medical Center. Dmand AI also links Dr. Wysham to 1 more hospital, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account. Dr. Wysham's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wysham practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Wysham's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Wysham's licenses on file in 2 states: Washington and Oregon.

CMS data shows 741 Medicare services from Dr. Wysham across 17 procedure codes in 2024, for 175 Medicare patients. Medicare paid $40,107 for them.

CMS counts 175 Medicare patients who saw Dr. Wysham in 2024. The largest group is 75 to 84, with 72 patients. 72% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wysham's median patient age at 73, with 58% women.

In 2024, Dr. Wysham wrote 1,268 Medicare Part D claims for 264 patients. 39% of them were for generic drugs. CMS names the drug for 1,093 of them, across 20 drugs with 11 or more claims each, at $571,376 in total drug cost. In 2023, CMS named 943 claims across 21 drugs.

Dr. Wysham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wysham as offering telehealth.

Dmand AI links 20 papers to Dr. Wysham, published from 2013 to 2021. 2016 was the busiest year, with 5. The most frequent topics are Palliative Care, Intensive Care Units and Critical Care. Dr. Wysham has published most often in Ann Am Thorac Soc. Dr. Wysham's most frequent co-authors are Arif H. Kamal, MD, Shannon S. Carson, MD and Thomas William Leblanc, MA, MD.

Dmand AI links Dr. Wysham to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Mycobacterium avium-intracellulare Infection, Pulmonary Disease, Chronic Obstructive and Lung Diseases, Obstructive.

CMS Open Payments shows 203 general payments to Dr. Wysham from 16 drug and device companies from 2017 to 2025. Education make up the largest share, 63% of the total. Intuitive Surgical, Inc. paid the most, $107,733.

Dr. Wysham graduated from University of Washington School of Medicine in 2009.